molecules-logo

Journal Browser

Journal Browser

Mesoporous Silica in Biomedical Applications

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (10 December 2017) | Viewed by 70931

Special Issue Editor


E-Mail Website
Guest Editor
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, Turku, Finland
Interests: nanomedicine; drug delivery; biomaterials engineering; bioimaging probes; biomedical nanotechnology; pharmaceutical technology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Mesoporous silica has emerged at the forefront of promising carrier materials under development, owing to its characteristic properties, including tuneable pore size and structure, extensive surface area and pore volume, flexible surface functionalization, as well as controllable particle sizes and shapes on the nanoscale. The advent of such mesoporous silica nanoparticles (MSNs) resulted in a boom of developments within intracellular drug delivery, highlighted by a multitude of successful proof-of-concept studies, especially within targeted cancer therapies. The vast applicability of these materials as delivery vehicles for virtually any active molecule of choice, including small-molecular drugs, peptides, proteins, nucleic acids, as well as imaging agents and sensing molecules, together with their modularity in design approaches, to date, has showcased some highly sophisticated systems. The mesoporous silica synthesis regime further allows for the construction of core–shell nanocomposites, which can further expand the multimodality of the final particle construct, since the core material can also be chosen, practically at will. With the first-in-man study published in 2016, this Special Issue aims to provide a forum for the dissemination of the latest developments and new approaches for the design, utilization, and evaluation of mesoporous silica in biomedicine.

Prof. Dr. Jessica Rosenholm
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Mesoporous silica nanoparticles (MSNs)
  • Drug delivery systems
  • Cancer treatment and diagnostics
  • Intracellular drug delivery
  • Targeted drug delivery
  • Stimuli-responsive drug release
  • Biomedical imaging and contrast agents
  • Photodynamic therapy
  • Nucleic acid delivery and gene therapy
  • Theranostics
  • Core-shell particles
  • Nanocomposites
  • Nanomedicine
  • Formulation design

Published Papers (9 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

9 pages, 2606 KiB  
Article
Large Pore Mesoporous Silica and Organosilica Nanoparticles for Pepstatin A Delivery in Breast Cancer Cells
by Saher Rahmani, Jelena Budimir, Mylene Sejalon, Morgane Daurat, Dina Aggad, Eric Vives, Laurence Raehm, Marcel Garcia, Laure Lichon, Magali Gary-Bobo, Jean-Olivier Durand and Clarence Charnay
Molecules 2019, 24(2), 332; https://doi.org/10.3390/molecules24020332 - 17 Jan 2019
Cited by 23 | Viewed by 4955
Abstract
(1) Background: Nanomedicine has recently emerged as a new area of research, particularly to fight cancer. In this field, we were interested in the vectorization of pepstatin A, a peptide which does not cross cell membranes, but which is a potent inhibitor of [...] Read more.
(1) Background: Nanomedicine has recently emerged as a new area of research, particularly to fight cancer. In this field, we were interested in the vectorization of pepstatin A, a peptide which does not cross cell membranes, but which is a potent inhibitor of cathepsin D, an aspartic protease particularly overexpressed in breast cancer. (2) Methods: We studied two kinds of nanoparticles. For pepstatin A delivery, mesoporous silica nanoparticles with large pores (LPMSNs) and hollow organosilica nanoparticles (HOSNPs) obtained through the sol–gel procedure were used. The nanoparticles were loaded with pepstatin A, and then the nanoparticles were incubated with cancer cells. (3) Results: LPMSNs were monodisperse with 100 nm diameter. HOSNPs were more polydisperse with diameters below 100 nm. Good loading capacities were obtained for both types of nanoparticles. The nanoparticles were endocytosed in cancer cells, and HOSNPs led to the best results for cancer cell killing. (4) Conclusions: Mesoporous silica-based nanoparticles with large pores or cavities are promising for nanomedicine applications with peptides. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

8086 KiB  
Article
Inkjet Printing of Drug-Loaded Mesoporous Silica Nanoparticles—A Platform for Drug Development
by Henrika Wickström, Ellen Hilgert, Johan O. Nyman, Diti Desai, Didem Şen Karaman, Thomas De Beer, Niklas Sandler and Jessica M. Rosenholm
Molecules 2017, 22(11), 2020; https://doi.org/10.3390/molecules22112020 - 21 Nov 2017
Cited by 45 | Viewed by 7911
Abstract
Mesoporous silica nanoparticles (MSNs) have shown great potential in improving drug delivery of poorly water soluble (BCS class II, IV) and poorly permeable (BCS class III, IV) drugs, as well as facilitating successful delivery of unstable compounds. The nanoparticle technology would allow improved [...] Read more.
Mesoporous silica nanoparticles (MSNs) have shown great potential in improving drug delivery of poorly water soluble (BCS class II, IV) and poorly permeable (BCS class III, IV) drugs, as well as facilitating successful delivery of unstable compounds. The nanoparticle technology would allow improved treatment by reducing adverse reactions of currently approved drugs and possibly reintroducing previously discarded compounds from the drug development pipeline. This study aims to highlight important aspects in mesoporous silica nanoparticle (MSN) ink formulation development for digital inkjet printing technology and to advice on choosing a method (2D/3D) for nanoparticle print deposit characterization. The results show that both unfunctionalized and polyethyeleneimine (PEI) surface functionalized MSNs, as well as drug-free and drug-loaded MSN–PEI suspensions, can be successfully inkjet-printed. Furthermore, the model BCS class IV drug remained incorporated in the MSNs and the suspension remained physically stable during the processing time and steps. This proof-of-concept study suggests that inkjet printing technology would be a flexible deposition method of pharmaceutical MSN suspensions to generate patterns according to predefined designs. The concept could be utilized as a versatile drug screening platform in the future due to the possibility of accurately depositing controlled volumes of MSN suspensions on various materials. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

3823 KiB  
Article
Novel Synthesis of Core-Shell Silica Nanoparticles for the Capture of Low Molecular Weight Proteins and Peptides
by Sergio G. Hernandez-Leon, Jose Andre-i Sarabia-Sainz, Gabriela Ramos-Clamont Montfort, Ana M. Guzman-Partida, Maria Del Refugio Robles-Burgueño and Luz Vazquez-Moreno
Molecules 2017, 22(10), 1712; https://doi.org/10.3390/molecules22101712 - 12 Oct 2017
Cited by 9 | Viewed by 8056
Abstract
Silica nanoparticles were functionalized with immobilized molecular bait, Cibacron Blue, and a porous polymeric bis-acrylamide shell. These nanoparticles represent a new alternative to capture low molecular weight (LMW) proteins/peptides, that might be potential biomarkers. Functionalized core-shell silica nanoparticles (FCSNP) presented a size distribution [...] Read more.
Silica nanoparticles were functionalized with immobilized molecular bait, Cibacron Blue, and a porous polymeric bis-acrylamide shell. These nanoparticles represent a new alternative to capture low molecular weight (LMW) proteins/peptides, that might be potential biomarkers. Functionalized core-shell silica nanoparticles (FCSNP) presented a size distribution of 243.9 ± 11.6 nm and an estimated surface charge of −38.1 ± 0.9 mV. The successful attachment of compounds at every stage of synthesis was evidenced by ATR-FTIR. The capture of model peptides was determined by mass spectrometry, indicating that only the peptide with a long sequence of hydrophobic amino acids (alpha zein 34-mer) interacted with the molecular bait. FCSNP excluded the high molecular weight protein (HMW), BSA, and captured LMW proteins (myoglobin and aprotinin), as evidenced by SDS-PAGE. Functionalization of nanoparticles with Cibacron Blue was crucial to capture these molecules. FCSNP were stable after twelve months of storage and maintained a capacity of 3.1–3.4 µg/mg. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

2889 KiB  
Article
Biomimetic-Functionalized, Tannic Acid-Templated Mesoporous Silica as a New Support for Immobilization of NHase
by Jun-kai Gao, Zi-jun Zhang, Yan-jun Jiang, Yan Chen and Shu-feng Gao
Molecules 2017, 22(10), 1597; https://doi.org/10.3390/molecules22101597 - 25 Sep 2017
Cited by 17 | Viewed by 4920
Abstract
Tannic acid-templated mesoporous silica (TAMS) was synthesized using a simple nonsurfactant template method and dopamine-functionalized TAMS (Dop-TAMS), which was prepared via a biomimetic coating, was developed as a new support for immobilization of NHase (NHase@Dop-TAMS). The Dop-TAMS was thoroughly characterized by the transmission [...] Read more.
Tannic acid-templated mesoporous silica (TAMS) was synthesized using a simple nonsurfactant template method and dopamine-functionalized TAMS (Dop-TAMS), which was prepared via a biomimetic coating, was developed as a new support for immobilization of NHase (NHase@Dop-TAMS). The Dop-TAMS was thoroughly characterized by the transmission electron microscopy (TEM), scanning electron microscopy (SEM), Brunauer–Emmett–Teller (BET), and Fourier transform infrared (FT-IR) and the results showed that the Dop-TAMS possessed sufficiently large pore size and volume for the accommodation of NHase. Studying the thermal stability, storage, shaking stability, and pH stability of the free and immobilized NHase indicated that the catalytic properties of NHase@Dop-TAMS were significantly enhanced. Moreover, the NHase@Dop-TAMS exhibited good reusability. All the results demonstrated that Dop-TAMS could be used as an excellent matrix for the immobilization of NHase. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

8438 KiB  
Article
Effects of Chlorhexidine-Encapsulated Mesoporous Silica Nanoparticles on the Anti-Biofilm and Mechanical Properties of Glass Ionomer Cement
by Huiyi Yan, Hongye Yang, Kang Li, Jian Yu and Cui Huang
Molecules 2017, 22(7), 1225; https://doi.org/10.3390/molecules22071225 - 21 Jul 2017
Cited by 36 | Viewed by 6945
Abstract
One of the primary causes for the failure of glass ionomer cement (GIC) is secondary caries. To enhance the anti-microbial performance of GIC without affecting its mechanical properties, chlorhexidine (CHX) was encapsulated in expanded-pore mesoporous silica nanoparticles (pMSN) to synthesize CHX@pMSN. CHX@pMSN was [...] Read more.
One of the primary causes for the failure of glass ionomer cement (GIC) is secondary caries. To enhance the anti-microbial performance of GIC without affecting its mechanical properties, chlorhexidine (CHX) was encapsulated in expanded-pore mesoporous silica nanoparticles (pMSN) to synthesize CHX@pMSN. CHX@pMSN was added at three mass fractions (1%, 5%, and 10% (w/w)) to GIC powder as the experimental groups. Pure GIC was set as the control group. The mechanical and anti-biofilm properties of GIC from each group were tested. The results demonstrated that CHX was successfully encapsulated on/into pMSN, and the encapsulating efficiency of CHX was 44.62% in CHX@pMSN. The anti-biofilm ability was significantly enhanced in all experimental groups (p < 0.001) compared with that in the control group. CHX was continuously released, and anti-biofilm ability was maintained up to 30 days. In addition, the mechanical properties (compressive strength, surface hardness, elastic modulus, water sorption, and solubility) of 1% (w/w) group were maintained compared with those in the control group (p > 0.05). In conclusion, adding 1% (w/w) CHX@pMSN to GIC led to conspicuous anti-biofilm ability and had no adverse effect on the mechanical properties of this restorative material. This study proposes a new strategy for preventing secondary caries by using CHX@pMSN-modified GIC. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Figure 1

20472 KiB  
Article
Synthesis of Pyrimethanil-Loaded Mesoporous Silica Nanoparticles and Its Distribution and Dissipation in Cucumber Plants
by Pengyue Zhao, Lidong Cao, Dukang Ma, Zhaolu Zhou, Qiliang Huang and Canping Pan
Molecules 2017, 22(5), 817; https://doi.org/10.3390/molecules22050817 - 16 May 2017
Cited by 37 | Viewed by 6766
Abstract
Mesoporous silica nanoparticles are used as pesticide carries in plants, which has been considered as a novel method to reduce the indiscriminate use of conventional pesticides. In the present work, mesoporous silica nanoparticles with particle diameters of 200–300 nm were synthesized in order [...] Read more.
Mesoporous silica nanoparticles are used as pesticide carries in plants, which has been considered as a novel method to reduce the indiscriminate use of conventional pesticides. In the present work, mesoporous silica nanoparticles with particle diameters of 200–300 nm were synthesized in order to obtain pyrimethanil-loaded nanoparticles. The microstructure of the nanoparticles was observed by scanning electron microscopy. The loading content of pyrimethanil-loaded nanoparticles was investigated. After treatment on cucumber leaves, the concentrations of pyrimethanil were determined in different parts of cucumber over a period of 48 days using high performance liquid chromatography tandem mass spectrometry. It was shown that the pyrimethanil-loaded mesoporous silica nanoparticles might be more conducive to acropetal, rather than basipetal, uptake, and the dosage had almost no effect on the distribution and dissipation rate in cucumber plants. The application of the pesticide-loaded nanoparticles in leaves had a low risk of pyrimethanil accumulating in the edible part of the plant. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

7767 KiB  
Article
Raspberry-Like Bismuth Oxychloride on Mesoporous Siliceous Support for Sensitive Electrochemical Stripping Analysis of Cadmium
by Yiyan Song, Zhihui Xu, Xinyu Yu, Xueyan Shi, Huijun Jiang, Xiaoming Li, Yan Kong, Qin Xu and Jin Chen
Molecules 2017, 22(5), 797; https://doi.org/10.3390/molecules22050797 - 13 May 2017
Cited by 8 | Viewed by 4591
Abstract
BiOCl-SiO2 KIT-6 composite materials with raspberry-like structures are facilely prepared under hydrothermal conditions. The mesoporous siliceous support of SiO2 KIT-6-incorporated BiOCl with enlarged yet refined surface morphology characterized by physiochemical methods exhibits an improved electrochemical performance. A sensitive electrochemical detection method [...] Read more.
BiOCl-SiO2 KIT-6 composite materials with raspberry-like structures are facilely prepared under hydrothermal conditions. The mesoporous siliceous support of SiO2 KIT-6-incorporated BiOCl with enlarged yet refined surface morphology characterized by physiochemical methods exhibits an improved electrochemical performance. A sensitive electrochemical detection method of cadmium concentration using square wave anodic stripping voltammetry was developed based on BiOCl-SiO2 KIT-6 composite-modified glassy carbon electrodes, which displayed wide linear ranges of 0.5 to 10 μg/L and 10 to 300 μg/L and a detection limit of 65 ng/L. The sensitive, versatile and eco-friendly sensor was successfully applied for the determination of cadmium-spiked human blood samples. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Graphical abstract

Review

Jump to: Research

3847 KiB  
Review
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
by María Vallet-Regí, Montserrat Colilla, Isabel Izquierdo-Barba and Miguel Manzano
Molecules 2018, 23(1), 47; https://doi.org/10.3390/molecules23010047 - 25 Dec 2017
Cited by 345 | Viewed by 18176
Abstract
This manuscript reviews the recent progress on mesoporous silica nanoparticles as drug delivery systems. Their intrinsic structural, textural and chemical features permit to design versatile multifunctional nanosystems with the capability to target the diseased tissue and release the cargo on demand upon exposition [...] Read more.
This manuscript reviews the recent progress on mesoporous silica nanoparticles as drug delivery systems. Their intrinsic structural, textural and chemical features permit to design versatile multifunctional nanosystems with the capability to target the diseased tissue and release the cargo on demand upon exposition to internal or external stimuli. The degradation rate of these nanocarriers in diverse physiological fluids is overviewed obeying their significance for their potential translation towards clinical applications. To conclude, the balance between the benefits and downsides of this revolutionary nanotechnological tool is also discussed. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Figure 1

38110 KiB  
Review
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications
by Wenzhang Cha, Rengen Fan, Yufeng Miao, Yong Zhou, Chenglin Qin, Xiangxiang Shan, Xinqiang Wan and Jinbo Li
Molecules 2017, 22(5), 782; https://doi.org/10.3390/molecules22050782 - 11 May 2017
Cited by 54 | Viewed by 7578
Abstract
Nucleic acids, including DNA, microRNA (miRNA), small interfering RNA (siRNA), and antisense oligonucleotide (ASO), are powerful gene regulators, which have been demonstrated as promising drug candidates for therapeutic treatments. Nevertheless, poor cellular membrane permeability and serum stability have greatly hindered the applications of [...] Read more.
Nucleic acids, including DNA, microRNA (miRNA), small interfering RNA (siRNA), and antisense oligonucleotide (ASO), are powerful gene regulators, which have been demonstrated as promising drug candidates for therapeutic treatments. Nevertheless, poor cellular membrane permeability and serum stability have greatly hindered the applications of nucleic acids in biomedicine. To address these issues, associate carriers that can encapsulate and protect nucleic acids are urgently required. Mesoporous silica nanoparticles (MSNs or MSNPs), which are nanomaterials with excellent biocompatibility, large surface area for functionalization, and tunable pore size for encapsulating different cargos, are emerging as novel and ideal biomaterials for different biomedical applications. In this review paper, we focus on the applications of MSNs in nucleic acid delivery and nucleic acid-guided therapeutic treatments. General strategies for the preparation of nucleic acid-MSN complexes will be firstly introduced, followed by a summary of recent applications of MSNs in nucleic acid delivery and nucleic acid-guided therapeutics. Full article
(This article belongs to the Special Issue Mesoporous Silica in Biomedical Applications)
Show Figures

Figure 1

Back to TopTop